Cargando…
Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth In Vitro
Cryptosporidium parvum and Cryptosporidium hominis have emerged as major enteric pathogens of infants in the developing world, in addition to their known importance in immunocompromised adults. Although there has been recent progress in identifying new small molecules that inhibit Cryptosporidium sp...
Autores principales: | Funkhouser-Jones, Lisa J., Ravindran, Soumya, Sibley, L. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064746/ https://www.ncbi.nlm.nih.gov/pubmed/32127445 http://dx.doi.org/10.1128/mBio.00052-20 |
Ejemplares similares
-
Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro
por: Wilke, Georgia, et al.
Publicado: (2018) -
Apical Secretory Glycoprotein Complex Contributes to Cell Attachment and Entry by Cryptosporidium parvum
por: Akey, Marianna E., et al.
Publicado: (2023) -
Microbiota-produced indole metabolites disrupt mitochondrial function and inhibit Cryptosporidium parvum growth
por: Funkhouser-Jones, Lisa J., et al.
Publicado: (2023) -
Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells
por: VanDussen, Kelli L., et al.
Publicado: (2020) -
Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
por: Nava, Maria G., et al.
Publicado: (2022)